Dow Down 1.40% Nasdaq Down 1.59%

More On 009420.KS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

HanAll Biopharma Co., Ltd. (009420.KS)

-KSE
4,340.00 Up 40.00(0.93%) 2:00AM EDT
Prev Close:4,300.00
Open:4,215.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:4,180.00 - 4,360.00
52wk Range:3,555.00 - 6,700.00
Volume:115,634
Avg Vol (3m):212,552
Market Cap:174.52B
P/E (ttm):N/A
EPS (ttm):-423.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in KRW.

Headlines

  • No Headlines available for 009420.KS at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

HanAll BioPharma Co., Ltd., a biopharmaceutical company, researches and develops biopharmaceutical products worldwide. It develops H176 and HL177, a series of anti-cancer agents for cancer metabolism; and HL156FIB, an EMT inhibitor for fibrotic di... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback